Patent · US Active

Pharmaceutical composition

US11865107B2 · kind B2 · utility

0Cited by
2References
15Claims
0Family size

Inventors

Key dates

Filing dateSep 2, 2020
Grant dateJan 9, 2024
Priority date
Expiry dateSep 2, 2040

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K47/46
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A composition comprising a therapeutically effective amount of at least one alkaloid combined with one or more non-alkaloid components, wherein the composition is configured to be administered to a subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.